ES2155621T3 - Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal. - Google Patents

Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.

Info

Publication number
ES2155621T3
ES2155621T3 ES96931039T ES96931039T ES2155621T3 ES 2155621 T3 ES2155621 T3 ES 2155621T3 ES 96931039 T ES96931039 T ES 96931039T ES 96931039 T ES96931039 T ES 96931039T ES 2155621 T3 ES2155621 T3 ES 2155621T3
Authority
ES
Spain
Prior art keywords
treatment
inflammatory disease
intestinal inflammatory
azo derivatives
aminosalicilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96931039T
Other languages
English (en)
Inventor
Elena Carceller
Pere J Jimenez
Jordi Salas
Carmen Almansa
Javier Bartroli
Manel Merlos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES9501752A external-priority patent/ES2106682B1/es
Priority claimed from ES9501967A external-priority patent/ES2104513B1/es
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Application granted granted Critical
Publication of ES2155621T3 publication Critical patent/ES2155621T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL COMPUESTO DE FORMULA (I), ASI COMO SUS SALES Y SOLVATOS, SON UTILES PARA EL TRATAMIENTO DEL SINDROME INFLAMATORIO INTESTINAL. SE PROPORCIONAN ASIMISMO, COMPOSICIONES QUE INCLUYEN DICHOS COMPUESTOS, Y PROCEDIMIENTOS DE PREPARACION DE LAS MISMAS.
ES96931039T 1995-09-08 1996-09-06 Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal. Expired - Lifetime ES2155621T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9501752A ES2106682B1 (es) 1995-09-08 1995-09-08 Nuevos derivados azo del acido 5-aminosalicilico.
ES9501967A ES2104513B1 (es) 1995-10-11 1995-10-11 Nuevos derivados del acido 5-aminosalicilico.

Publications (1)

Publication Number Publication Date
ES2155621T3 true ES2155621T3 (es) 2001-05-16

Family

ID=26154915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96931039T Expired - Lifetime ES2155621T3 (es) 1995-09-08 1996-09-06 Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.

Country Status (17)

Country Link
US (1) US5747477A (es)
EP (1) EP0790998B1 (es)
JP (1) JP4115522B2 (es)
KR (1) KR100481300B1 (es)
AR (1) AR004198A1 (es)
AT (1) ATE198751T1 (es)
AU (1) AU6987596A (es)
BR (1) BR9606628A (es)
CA (1) CA2204747C (es)
DE (1) DE69611598T2 (es)
DK (1) DK0790998T3 (es)
ES (1) ES2155621T3 (es)
GR (1) GR3035622T3 (es)
MX (1) MX9702919A (es)
NO (1) NO308850B1 (es)
PT (1) PT790998E (es)
WO (1) WO1997009329A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958324B2 (en) * 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
ES2165803B1 (es) * 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
WO2001098268A2 (en) 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
WO2002018324A2 (en) 2000-08-29 2002-03-07 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030119792A1 (en) * 2001-09-28 2003-06-26 Roca Manuel Merlos Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
WO2006125293A1 (en) 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7741359B2 (en) 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
US7498355B2 (en) 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20110144188A1 (en) 2006-06-06 2011-06-16 Antibe Therapeutics Inc. Salts of trimebutine and n-desmethyl trimebutine
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
CN105566153B (zh) * 2014-10-14 2019-05-31 中国医学科学院药物研究所 偶氮苯衍生物及其制法和药物组合物与用途
KR102173168B1 (ko) 2018-06-19 2020-11-03 주식회사 엠디헬스케어 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물
WO2019245225A1 (ko) 2018-06-19 2019-12-26 (주)코엔바이오 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
US4312806A (en) * 1981-03-02 1982-01-26 G. D. Searle & Co. Method and compounds for treating inflammatory bowel disease
IE70217B1 (en) * 1990-08-15 1996-10-30 British Bio Technology Benzimidazole derivatives process for their preparation and application
GB9202791D0 (en) * 1992-02-11 1992-03-25 British Bio Technology Compounds
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.

Also Published As

Publication number Publication date
JPH11501939A (ja) 1999-02-16
JP4115522B2 (ja) 2008-07-09
MX9702919A (es) 1998-04-30
NO972113L (no) 1997-05-07
US5747477A (en) 1998-05-05
NO308850B1 (no) 2000-11-06
AR004198A1 (es) 1998-11-04
ATE198751T1 (de) 2001-02-15
CA2204747A1 (en) 1997-03-13
NO972113D0 (no) 1997-05-07
DK0790998T3 (da) 2001-02-05
WO1997009329A1 (en) 1997-03-13
KR100481300B1 (ko) 2005-07-29
CA2204747C (en) 2009-05-05
DE69611598T2 (de) 2001-06-07
GR3035622T3 (en) 2001-06-29
BR9606628A (pt) 1997-09-30
EP0790998A1 (en) 1997-08-27
EP0790998B1 (en) 2001-01-17
KR970707125A (ko) 1997-12-01
AU6987596A (en) 1997-03-27
PT790998E (pt) 2001-04-30
DE69611598D1 (de) 2001-02-22

Similar Documents

Publication Publication Date Title
ES2155621T3 (es) Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
ES2112377T3 (es) Procedimiento para la preparacion de derivados del taxano y productos intermedios.
ES2150113T3 (es) Derivados de pirazol y procedimientos para la preparacion de los mismos.
ECSP045347A (es) "derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso"
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
ES2101063T3 (es) Derivados monofluorados de n-propargil-1-amino-indano y su utilizacion como inhibidores de la monoamin-oxidasa.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
AR002267A1 (es) Compuestos de imidazol utiles para el tratamiento de patologias mediadas por citoquinas; composicion farmaceutica que los contiene; proceso para preparar dichos compuestos; uso del mismo para preparar dichas composiciones; compuestos intermediarios y procesos para su preparacion.
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ECSP055680A (es) Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf)
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR003955A1 (es) Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen.
ECSP055681A (es) Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf)
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
TR200000671T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
CR7195A (es) Nuevos derivados de oxazolidinonas como antibacterianos
SE9804212D0 (sv) Compounds
PA8467301A1 (es) Nuevos derivados del acido dihidroxihexanoico
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 790998

Country of ref document: ES